SEC Form 4 · accession 0001615774-18-014984
Motus GI Holdings, Inc. · MOTS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David P Hochman
Director · Other
Period of report
Dec 24, 2018
Accepted (ET)
Dec 26, 2018 · 5:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001686850
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share | Dec 24, 2018 | P | 20,000 | $2.70 | A | 100,000 | I | By DPH 2008 Trust |
| Common Stock, par value $0.0001 per share | holding | — | — | — | 18,000 | D | ||
| Common Stock, par value $0.0001 per shareF2 | holding | — | — | — | 109,792 | I | By Orchestra Medical Ventures II, L.P. | |
| Common Stock, par value $0.0001 per shareF3 | holding | — | — | — | 2,000,000 | I | By Orchestra BioMed, Inc. | |
| Common Stock, par value $0.0001 per shareF4 | holding | — | — | — | 1,159,968 | I | By Orchestra MOTUS Co-Investment Partners, LLC | |
| Common Stock, par value $0.0001 per shareF5 | holding | — | — | — | 83,352 | I | By Orchestra Medical Ventures II Reserve, L.P. | |
| Common Stock, par value $0.0001 per shareF6 | holding | — | — | — | 51,498 | I | By Accelerated Technologies, Inc. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The securities were purchased pursuant to an underwritten public offering by the Issuer. The offering closed on December 24, 2018.
- F2The securities are directly held by Orchestra Medical Ventures II, L.P. ("OMV II"). Orchestra Medical Ventures II GP, LLC ("OMV GP") serves as general partner to OMV II. Reporting Person and Darren Sherman are the managing members of OMV GP. Reporting Person and Mr. Sherman jointly exercise dispositive and voting power over the shares owned by OMV II. Each of Reporting Person, Mr. Sherman and OMV GP disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person, Mr. Sherman or OMV GP is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
- F3The securities are directly held by Orchestra BioMed, Inc., a Delaware corporation ("OBIO"). Reporting Person, Mr. Sherman and Geoffrey W. Smith are the directors of OBIO. Reporting Person, Mr. Sherman and Mr. Smith jointly exercise dispositive and voting power over the shares owned by OBIO. Each of Reporting Person, Mr. Sherman and Mr. Smith disclaim, for purposes of Section 16, beneficial ownership of such securities, except to the extent of their indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person, Mr. Sherman or Mr. Smith are the beneficial owners of such securities for purposes of Section 16 or for any other purposes.
- F4The securities are directly held by Orchestra MOTUS Co-Investment Partners, LLC ("OMCP"). Orchestra Medical Ventures, LLC ("OMV LLC") serves as managing member to OMCP. Reporting Person and Mr. Sherman are the managing partners of OMV LLC. Reporting Person and Mr. Sherman jointly exercise dispositive and voting power over the shares owned by OMCP. Each of Reporting Person, Mr. Sherman and OMV LLC disclaims, for purposes of Section 16, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person, Mr. Sherman or OMV LLC is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
- F5The securities are directly held by Orchestra Medical Ventures II Reserve, L.P. ("OMV Reserve"). OMV GP serves as general partner to OMV Reserve. Reporting Person and Mr. Sherman are the managing members of OMV GP. Reporting Person and Mr. Sherman jointly exercise dispositive and voting power over the shares owned by OMV Reserve. Each of Reporting Person, Mr. Sherman and OMV GP disclaims, for purposes of Section 16, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person, Mr. Sherman or OMV GP is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
- F6The securities are directly held by Accelerated Technologies, Inc. ("ATI"). Reporting Person and Mr. Sherman jointly exercise dispositive and voting power over the shares owned by ATI. Each of Reporting Person and Mr. Sherman disclaims, for purposes of Section 16, beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person or Mr. Sherman is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.